Logo-jcvtr
Submitted: 21 Sep 2017
Revision: 13 Mar 2018
Accepted: 27 Apr 2018
ePublished: 28 May 2018
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Cardiovasc Thorac Res. 2018;10(2): 56-69.
doi: 10.15171/jcvtr.2018.10
PMID: 30116503
PMCID: PMC6088762
  Abstract View: 1251
  PDF Download: 891

Review Article

Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis

Jamal Hallajzadeh 1, Maliheh Khoramdad 2, Nahid Karamzad 3, Amir Almasi-Hashiani 4, Ali Janati 5, Erfan Ayubi 6, Reza Pakzad 7, Mark J.M. Sullman 8, Saeid Safiri 1,9 *

Abstract

Introduction: The objectives of this study were to provide an estimate of the prevalence of metabolic syndrome (MetS) and its components among women with PCOS; and calculate the odds ratio (OR) for MetS (using different definitions of MetS) in women with PCOS, compared to healthy controls.
Methods: All of the relevant databases were used to search for appropriate articles that were published during the period 2003-2016. We included observational studies (cross-sectional, comparative cross-sectional) among women who met the inclusion criteria. The random-effect models were used to pool the prevalence of MetS and its components among PCOS women. This model was also applied to the pooled OR assessing the association between MetS and PCOS.
Results: The pooled prevalence of MetS among PCOS women was found to be 26.30% (95% CI: 23.68–28.93), but varied from 7.10% (95% CI: 1.64-12.56) to 37.50% (95% CI: 28.84-46.16), depending upon the diagnostic criteria used. Low high-density lipoprotein cholesterol (HDL) - 61.87% (95% CI: 53.31–70.43) and high waist circumference (WC)- 52.23% (95% CI: 43.84–60.61) were the most common components of MetS in PCOS women. Compared to healthy controls, the overall pooled (OR) of MetS in PCOS patients was 2.09 (95% CI: 1.67-2.60), but this ranged from 0.31 (95% CI: 0.13-0.74) to 4.69 (95% CI: 2.09-10.52), depending upon the diagnostic criteria used.
Conclusion: Women with PCOS had a much higher prevalence of MetS than was found among the healthy controls. Furthermore, as low HDL and high WC were the most common components of MetS in PCOS women, these two components specifically need to be addressed in prevention strategies.
Keywords: Global, Metabolic Syndrome, Prevalence, Polycystic Ovary Syndrome, Meta-Analysis
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 1251

Your browser does not support the canvas element.


PDF Download: 891

Your browser does not support the canvas element.